Nanjangud: Even as Nanjangud’s Jubilant Generics COVID-19 cluster cases have become a cause of grave concern in Mysuru district, Nanjangud MLA B. Harshavardhan said that the Pharmaceutical Unit will not be allowed to re-open until full contact-tracing and enquiry into the origin of the infection is completed. Speaking to presspersons here yesterday, Harshavardhan said that the…
Mysore/Mysuru: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has in a press release, said that it is providing support to the State Government in its effort to deliver effective health and safety services to manage COVID-19 crisis and has contributed a sum of Rs. 25 lakh towards the Chief Minister’s…
Mysore/Mysuru: With the COVID-19 lockdown affecting everyone, District Minister V. Somanna has asked the officials to ensure that no one suffers from hunger in the district. The Minister was addressing officials at KEB Engineers Association auditorium at Kadakola on Nanjangud Road yesterday after visiting Jubilant Organics at Nanjangud, which has now become the epicentre of…
Mysore/Mysuru: Mysuru reported two more positive cases for Coronavirus on the night of Apr.1, taking the total to 19. Among them one is a woman, the wife of P-52 the employee of Nanjangud-based pharmaceutical company (Jubilant Generics) who was tested as third positive case in the district a week ago. According to the latest health…
Mysore/Mysuru: Even as the Union Government declared Mysuru 21st among nationwide COVID-19 hotspots, the number of Coronavirus cases continues to rise in Mysuru district with three more persons testing positive today. Of the three new COVID-19 cases, two cases are from the Nanjangud-based pharmaceutical company (Jubilant Generics) that already had 12 positive cases and the third…
Children make merryNovember 14, 2024
Survey numbers missing in MUDA-approved layou...November 14, 2024
‘Priority for girl children’s education’November 14, 2024
Maharani’s students urge CM for Indira Cantee...November 14, 2024
Recent Comments